BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19702123)

  • 21. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease.
    Rossouw JE
    Ann N Y Acad Sci; 2006 Nov; 1089():444-53. PubMed ID: 17261787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oestrogens and the heart.
    Rosano GM; Panina G
    Therapie; 1999; 54(3):381-5. PubMed ID: 10500455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions.
    Ouyang P; Michos ED; Karas RH
    J Am Coll Cardiol; 2006 May; 47(9):1741-53. PubMed ID: 16682298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Benefits and risks in hormone substitute therapy in postmenopause].
    Baljić T
    Srp Arh Celok Lek; 1996; 124(5-6):143-6. PubMed ID: 9102835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Bittner V
    Expert Opin Pharmacother; 2009 Sep; 10(13):2041-53. PubMed ID: 19563274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of The North American Menopause Society.
    Menopause; 2000; 7(2):87-95. PubMed ID: 10746890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can menopause be considered an independent risk factor for cardiovascular disease?
    Mercuro G; Zoncu S; Cherchi A; Rosano GM
    Ital Heart J; 2001 Oct; 2(10):719-27. PubMed ID: 11721715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biological and practical aspects of hormone replacement therapy: an approach to cardiovascular disease prevention in postmenopausal women].
    da Silva PM
    Rev Port Cardiol; 1999 Nov; 18(11):1047-55. PubMed ID: 10608165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managing cardiovascular risk in menopausal women.
    Rosano GM; Vitale C; Tulli A
    Climacteric; 2006 Sep; 9 Suppl 1():19-27. PubMed ID: 16899440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of postmenopausal hypertension.
    Sjöberg L; Kaaja R; Tuomilehto J
    Int J Clin Pract Suppl; 2004 Mar; (139):4-12. PubMed ID: 15117107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hormone replacement therapy and cardiovascular prevention: many statements, some doubts].
    Motolese M
    Ital Heart J Suppl; 2003 Jul; 4(7):545-58. PubMed ID: 14558283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quantitative evaluation of the cardiovascular risk associated with hormone substitution therapy during menopause].
    Scarabin PY; Plu-Bureau G
    Arch Mal Coeur Vaiss; 1993 Feb; 86(2):243-8. PubMed ID: 8363427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Postmenopausal hormone replacement and cardiovascular disease].
    Oian P; Aune B
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):193-6. PubMed ID: 8430399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Premature ovarian failure, endothelial dysfunction and estrogen-progestogen replacement.
    Kalantaridou SN; Naka KK; Bechlioulis A; Makrigiannakis A; Michalis L; Chrousos GP
    Trends Endocrinol Metab; 2006 Apr; 17(3):101-9. PubMed ID: 16515863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention.
    Vitale C; Miceli M; Rosano GM
    Climacteric; 2007 Oct; 10 Suppl 2():16-20. PubMed ID: 17882667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis.
    Atsma F; Bartelink ML; Grobbee DE; van der Schouw YT
    Menopause; 2006; 13(2):265-79. PubMed ID: 16645540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women.
    Psaty BM; Heckbert SR; Atkins D; Siscovick DS; Koepsell TD; Wahl PW; Longstreth WT; Weiss NS; Wagner EH; Prentice R
    Arch Intern Med; 1993 Jun; 153(12):1421-7. PubMed ID: 8512434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.